Targeting of TAMs: can we be more clever than cancer cells?
With increasing incidence and geography, cancer is one of the leading causes of death, reduced quality of life and disability worldwide. Principal progress in the development of new anticancer therapies, in improving the efficiency of immunotherapeutic tools, and in the personification of convention...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
08 November 2024
|
| In: |
Cellular & molecular immunology
Year: 2024, Volume: 21, Issue: 12, Pages: 1376-1409 |
| ISSN: | 2042-0226 |
| DOI: | 10.1038/s41423-024-01232-z |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41423-024-01232-z Verlag, kostenfrei, Volltext: http://www.nature.com/articles/s41423-024-01232-z 
|
| Author Notes: | Julia Kzhyshkowska, Jiaxin Shen and Irina Larionova |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1922868981 | ||
| 003 | DE-627 | ||
| 005 | 20250717010054.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250414s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41423-024-01232-z |2 doi | |
| 035 | |a (DE-627)1922868981 | ||
| 035 | |a (DE-599)KXP1922868981 | ||
| 035 | |a (OCoLC)1528044599 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kzhyshkowska, Julia |d 1967- |e VerfasserIn |0 (DE-588)102414271X |0 (DE-627)719213754 |0 (DE-576)368002233 |4 aut | |
| 245 | 1 | 0 | |a Targeting of TAMs: can we be more clever than cancer cells? |c Julia Kzhyshkowska, Jiaxin Shen and Irina Larionova |
| 264 | 1 | |c 08 November 2024 | |
| 300 | |a 34 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 14.04.2025 | ||
| 520 | |a With increasing incidence and geography, cancer is one of the leading causes of death, reduced quality of life and disability worldwide. Principal progress in the development of new anticancer therapies, in improving the efficiency of immunotherapeutic tools, and in the personification of conventional therapies needs to consider cancer-specific and patient-specific programming of innate immunity. Intratumoral TAMs and their precursors, resident macrophages and monocytes, are principal regulators of tumor progression and therapy resistance. Our review summarizes the accumulated evidence for the subpopulations of TAMs and their increasing number of biomarkers, indicating their predictive value for the clinical parameters of carcinogenesis and therapy resistance, with a focus on solid cancers of non-infectious etiology. We present the state-of-the-art knowledge about the tumor-supporting functions of TAMs at all stages of tumor progression and highlight biomarkers, recently identified by single-cell and spatial analytical methods, that discriminate between tumor-promoting and tumor-inhibiting TAMs, where both subtypes express a combination of prototype M1 and M2 genes. Our review focuses on novel mechanisms involved in the crosstalk among epigenetic, signaling, transcriptional and metabolic pathways in TAMs. Particular attention has been given to the recently identified link between cancer cell metabolism and the epigenetic programming of TAMs by histone lactylation, which can be responsible for the unlimited protumoral programming of TAMs. Finally, we explain how TAMs interfere with currently used anticancer therapeutics and summarize the most advanced data from clinical trials, which we divide into four categories: inhibition of TAM survival and differentiation, inhibition of monocyte/TAM recruitment into tumors, functional reprogramming of TAMs, and genetic enhancement of macrophages. | ||
| 650 | 4 | |a Monocytes and macrophages | |
| 650 | 4 | |a Tumour immunology | |
| 700 | 1 | |a Shen, Jiaxin |d 1995- |e VerfasserIn |0 (DE-588)1363036513 |0 (DE-627)192286952X |4 aut | |
| 700 | 1 | |a Larionova, Irina |e VerfasserIn |0 (DE-588)133968845X |0 (DE-627)1899300457 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cellular & molecular immunology |d London [u.a.] : Nature Publ. Group, 2004 |g 21(2024), 12, Seite 1376-1409 |h Online-Ressource |w (DE-627)506719189 |w (DE-600)2219471-X |w (DE-576)281299099 |x 2042-0226 |7 nnas |a Targeting of TAMs: can we be more clever than cancer cells? |
| 773 | 1 | 8 | |g volume:21 |g year:2024 |g number:12 |g pages:1376-1409 |g extent:34 |a Targeting of TAMs: can we be more clever than cancer cells? |
| 856 | 4 | 0 | |u https://doi.org/10.1038/s41423-024-01232-z |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://www.nature.com/articles/s41423-024-01232-z |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250414 | ||
| 993 | |a Article | ||
| 994 | |a 2024 | ||
| 998 | |g 1363036513 |a Shen, Jiaxin |m 1363036513:Shen, Jiaxin |p 2 | ||
| 998 | |g 102414271X |a Kzhyshkowska, Julia |m 102414271X:Kzhyshkowska, Julia |d 60000 |d 63500 |e 60000PK102414271X |e 63500PK102414271X |k 0/60000/ |k 1/60000/63500/ |p 1 |x j | ||
| 999 | |a KXP-PPN1922868981 |e 4705343298 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title_sort":"Targeting of TAMs: can we be more clever than cancer cells?","title":"Targeting of TAMs: can we be more clever than cancer cells?"}],"language":["eng"],"recId":"1922868981","origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"08 November 2024"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"doi":["10.1038/s41423-024-01232-z"],"eki":["1922868981"]},"physDesc":[{"extent":"34 S."}],"relHost":[{"pubHistory":["2004, 01 [?]-"],"language":["eng"],"part":{"volume":"21","text":"21(2024), 12, Seite 1376-1409","year":"2024","issue":"12","extent":"34","pages":"1376-1409"},"title":[{"title":"Cellular & molecular immunology","title_sort":"Cellular & molecular immunology"}],"recId":"506719189","origin":[{"publisher":"Nature Publ. Group ; Univ.","dateIssuedDisp":"2004-","dateIssuedKey":"2004","publisherPlace":"London [u.a.] ; Hefei"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"Cellular and molecular immunology"}],"note":["China-Zeitschriften-Code: CN11-4987","CAJ control code: CMIT","Gesehen am 10.04.2025","Weipu Journal ID: 87787X"],"disp":"Targeting of TAMs: can we be more clever than cancer cells?Cellular & molecular immunology","physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["506719189"],"zdb":["2219471-X"],"issn":["2042-0226"]},"name":{"displayForm":["School of Life Sciences, University of Science & Technology of China"]}}],"note":["Gesehen am 14.04.2025"],"name":{"displayForm":["Julia Kzhyshkowska, Jiaxin Shen and Irina Larionova"]},"person":[{"given":"Julia","role":"aut","display":"Kzhyshkowska, Julia","family":"Kzhyshkowska"},{"family":"Shen","display":"Shen, Jiaxin","given":"Jiaxin","role":"aut"},{"family":"Larionova","given":"Irina","role":"aut","display":"Larionova, Irina"}]} | ||
| SRT | |a KZHYSHKOWSTARGETINGO0820 | ||